Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Priyanka Sharma, MD, University of Kansas Medical Center, Westwood, KS, USA, discusses results from the phase II randomized trial (NCT02595905) of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).